Finance

Beta
Lists
SIGHT:EPA
Gensight Biologics SA
0,084 €
0,00%
(0,00) 1D
9-июн., 11:27:10 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SIGHT...
Open
0,08 €
High
0,08 €
Low
0,08 €
Mkt. cap
20,56 млн
Avg. vol.
710,22 миң
Volume
51,71 миң
52-wk high
0,25 €
52-wk low
0,08 €
EPS
-0,08 €
Shares outstanding
235,04 млн
No. of employees
13
Open
0,08 €
High
0,08 €
Low
0,08 €
Mkt. cap
20,56 млн
Avg. vol.
710,22 миң
Volume
51,71 миң
52-wk high
0,25 €
52-wk low
0,08 €
EPS
-0,08 €
Shares outstanding
235,04 млн
No. of employees
13
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to SIGHT in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for SIGHT in the last 3 months.
Highest
Current 0,08 €
0,40 € (+378,47%)
Average
0,40 € (+378,47%)
Lowest
0,40 € (+378,47%)
News stories
From sources across the web
About Gensight Biologics SA
CEO-
Employees13
Founded2012
HeadquartersПариж, Иль-де-Франция, Франция
Sector-
Websitegensight-biologics.com
Last report
2026-ж., 8-янв.
Fiscal period
Q4 2025
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
302,00 миң / -
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
24,00 миң
24,00 миң
302,00 миң
302,00 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,14 млн
2,14 млн
1,08 млн
1,08 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,28 млн
1,28 млн
1,36 млн
1,36 млн
Operating expense
3,42 млн
3,42 млн
2,43 млн
2,43 млн
Total operating expenses
3,42 млн
3,42 млн
2,43 млн
2,43 млн
Operating income
-3,40 млн
-3,40 млн
-2,13 млн
-2,13 млн
Other non operating income
697,00 миң
697,00 миң
436,00 миң
436,00 миң
EBT including unusual items
-3,49 млн
-3,49 млн
-2,53 млн
-2,53 млн
EBT excluding unusual items
-3,49 млн
-3,49 млн
-2,53 млн
-2,53 млн
Income tax expense
-4,50 миң
-4,50 миң
2,00 миң
2,00 миң
Effective tax rate
0,13%
0,13%
-0,08%
-0,08%
Other operating expenses
-
-
-
-
Net income
-3,48 млн
-3,48 млн
-2,53 млн
-2,53 млн
Net profit margin
-14 514,58%
-14 514,58%
-839,24%
-839,24%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-660,00 миң
-660,00 миң
-784,50 миң
-784,50 миң
Net interest expenses
-660,00 миң
-660,00 миң
-784,50 миң
-784,50 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,36 млн
-3,36 млн
-2,09 млн
-2,09 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer